JP2005500373A - モルヒネ様オピオイド化合物の誘導体 - Google Patents

モルヒネ様オピオイド化合物の誘導体 Download PDF

Info

Publication number
JP2005500373A
JP2005500373A JP2003519071A JP2003519071A JP2005500373A JP 2005500373 A JP2005500373 A JP 2005500373A JP 2003519071 A JP2003519071 A JP 2003519071A JP 2003519071 A JP2003519071 A JP 2003519071A JP 2005500373 A JP2005500373 A JP 2005500373A
Authority
JP
Japan
Prior art keywords
compound
formula
group
substituted
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2003519071A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005500373A5 (cg-RX-API-DMAC7.html
Inventor
ジャクソン、ウイリアム、ロイ
スバシィンゲ、カマニ、ルピカ
Original Assignee
ポリチップ ファーマスーティカルズ プロプライエタリイ リミテッド
モナシュ ユニバーシティ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPR6938A external-priority patent/AUPR693801A0/en
Priority claimed from AUPR9640A external-priority patent/AUPR964001A0/en
Application filed by ポリチップ ファーマスーティカルズ プロプライエタリイ リミテッド, モナシュ ユニバーシティ filed Critical ポリチップ ファーマスーティカルズ プロプライエタリイ リミテッド
Publication of JP2005500373A publication Critical patent/JP2005500373A/ja
Publication of JP2005500373A5 publication Critical patent/JP2005500373A5/ja
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/09—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
    • C07D489/10—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
    • C07D489/12—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14 the bridge containing only two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
JP2003519071A 2001-08-10 2002-08-09 モルヒネ様オピオイド化合物の誘導体 Abandoned JP2005500373A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPR6938A AUPR693801A0 (en) 2001-08-10 2001-08-10 Therapeutic compounds
AUPR9640A AUPR964001A0 (en) 2001-12-19 2001-12-19 Therapeutic compounds
PCT/AU2002/001088 WO2003014122A1 (en) 2001-08-10 2002-08-09 Derivatives of morphine-like opioid compounds

Publications (2)

Publication Number Publication Date
JP2005500373A true JP2005500373A (ja) 2005-01-06
JP2005500373A5 JP2005500373A5 (cg-RX-API-DMAC7.html) 2006-01-05

Family

ID=25646773

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003519071A Abandoned JP2005500373A (ja) 2001-08-10 2002-08-09 モルヒネ様オピオイド化合物の誘導体

Country Status (7)

Country Link
US (1) US7199129B2 (cg-RX-API-DMAC7.html)
EP (1) EP1423392B1 (cg-RX-API-DMAC7.html)
JP (1) JP2005500373A (cg-RX-API-DMAC7.html)
AT (1) ATE341552T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002322169B2 (cg-RX-API-DMAC7.html)
DE (1) DE60215195T2 (cg-RX-API-DMAC7.html)
WO (1) WO2003014122A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040204862A1 (en) * 2003-04-11 2004-10-14 Wainer Irving W. Computer-based model for identification and characterization for non-competitive inhibitors of nicotinic acetylcholine receptors and related ligand-gated ion channel receptors
TWI630208B (zh) 2008-12-08 2018-07-21 歐陸斯迪公司 二氫羥戊甲嗎啡
US9351973B2 (en) 2011-09-22 2016-05-31 Merck Sharp & Dohme Corp. Pyrazolopyridyl compounds as aldosterone synthase inhibitors
WO2013043518A1 (en) 2011-09-22 2013-03-28 Merck Sharp & Dohme Corp. Imidazopyridyl compounds as aldosterone synthase inhibitors
EP2757883B1 (en) 2011-09-22 2021-01-13 Merck Sharp & Dohme Corp. Triazolopyridyl compounds as aldosterone synthase inhibitors
WO2014015157A2 (en) 2012-07-19 2014-01-23 Philadelphia Health & Education Corporation Novel sigma receptor ligands and methods of modulating cellular protein homeostasis using same
GB201309654D0 (en) 2013-05-30 2013-07-17 Euro Celtique Sa Method
US9920836B2 (en) * 2013-10-18 2018-03-20 Kabushiki Kaisha Riken Piston ring for internal combustion engine
US11117870B2 (en) 2017-11-01 2021-09-14 Drexel University Compounds, compositions, and methods for treating diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3341538A (en) * 1965-06-18 1967-09-12 Geigy Chem Corp Certain 2, 6-methano-3-benzazocines
WO1999038869A1 (en) 1998-01-29 1999-08-05 Monash University Therapeutic compounds
KR100602929B1 (ko) * 2000-08-31 2006-07-20 에프. 호프만-라 로슈 아게 알파-1 아드레날린성 길항제로서 퀴나졸린 유도체

Also Published As

Publication number Publication date
WO2003014122A1 (en) 2003-02-20
EP1423392A4 (en) 2004-11-17
ATE341552T1 (de) 2006-10-15
US20040242616A1 (en) 2004-12-02
DE60215195D1 (de) 2006-11-16
US7199129B2 (en) 2007-04-03
DE60215195T2 (de) 2007-08-23
EP1423392A1 (en) 2004-06-02
EP1423392B1 (en) 2006-10-04
AU2002322169B2 (en) 2008-10-30

Similar Documents

Publication Publication Date Title
JP6794602B2 (ja) ポリアミド化合物及びその使用
KR102038260B1 (ko) 히드로코돈의 벤조산, 벤조산 유도체 및 헤테로아릴 카르복실산 콘쥬게이트, 이의 전구약물, 제조 방법 및 용도
US8871780B2 (en) Phenylethanoic acid, phenylpropanoic acid and phenylpropenoic acid conjugates and prodrugs of hydrocodone, method of making and use thereof
US6784186B1 (en) Therapeutic compounds
KR20090086627A (ko) 프로드러그 및 그것의 제조 및 사용 방법
CN104812388A (zh) 新型化合物、其合成及其用途
KR20150065873A (ko) 케타민 유도체
CN102341389A (zh) 含氟化合物和其使用方法
EP1423392B1 (en) Derivatives of morphine-like opioid compounds
JP6013345B2 (ja) 痛み治療用の4,5a−エポキシモルフィナンの6−アミド誘導体
AU2002322169A1 (en) Derivatives of morphine-like opioid compounds
ITFI20100001A1 (it) Composti ad efficacia sia analgesica che antiperalgesica.
US20060111381A1 (en) Amidine compounds
JP2005500373A5 (cg-RX-API-DMAC7.html)
JP2022539197A (ja) Nmda受容体の調節因子
AU2003266841A1 (en) Amidine compounds
JPH0262544B2 (cg-RX-API-DMAC7.html)
AU757975C (en) Therapeutic compounds
TW399056B (en) Long analgesic acting nalbuphine polyester derivative and method of use
US20060217414A1 (en) High affinity ligands for nociceptin receptor ORL-1
HK40100661A (en) Phosphonates as inhibitors of enpp1 and cdnp
TW201540714A (zh) N-經取代之降伊波加因鹼(noribogaine)前藥
WO2013043558A1 (en) Compositions and methods for treating cancer

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050805

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050805

A762 Written abandonment of application

Free format text: JAPANESE INTERMEDIATE CODE: A762

Effective date: 20060117

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20060117